Robot and VR join forces to spot hidden stroke deficits

NCT ID NCT07290218

Not yet recruiting Knowledge-focused Sponsor: Fondazione Don Carlo Gnocchi Onlus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new robotic and virtual reality system called NeglectARm 3D in 15 people who have spatial neglect after a stroke. The system uses a robot arm and VR headset to measure how well patients notice objects in 3D space. Researchers want to see if the device is easy to use, safe, and gives reliable results compared to standard paper tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Non-CE-marked robotic device (NeglectARm 3D) with virtual reality headset
What this could lead to: If successful, this could lead to a more precise, objective tool for diagnosing spatial neglect after stroke, improving rehabilitation planning.
What could go wrong: This is a very small early-stage study (15 participants) focused on feasibility, not treatment. The device is not yet approved, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN INJURED PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury hemorrhagic stroke ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN INJURED PATIENTS NEGLECT POST-STROKE COGNITIVE IMPAIRMENT STROKE UNILATERAL SPATIAL NEGLECT (USN)

Contacts and locations

Locations

Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

Sant'Angelo dei Lombardi, AV, 83054, Italy
IRCSS Fondazione Don Carlo Gnocchi

Florence, FI, 50143, Italy
Scuola Superiore Sant'Anna

Pisa, PI, 56127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.